141 related articles for article (PubMed ID: 37011035)
1. Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity.
Yang Z; Cai Y; Yang X; Li Y; Wu Q; Yu Y; Chen Z; Wei B; Tian JM; Bao X; Ye X; Chen J; Zhang H; Mou X; Sun X; Wang H
J Med Chem; 2023 Apr; 66(8):5550-5566. PubMed ID: 37011035
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell.
Yang Z; Yang X; Li Y; Cai Y; Yu Y; Zhuang W; Sun X; Li Q; Bao X; Ye X; Tian J; Wei B; Chen J; Wu Q; Zhang H; Mou X; Wang H
Eur J Med Chem; 2023 Feb; 248():115092. PubMed ID: 36645980
[TBL] [Abstract][Full Text] [Related]
3. Discovery of 2,5-disubstituted furan derivatives featuring a benzamide motif for overcoming P-glycoprotein mediated multidrug resistance in MCF-7/ADR cell.
Yang Z; Cai Y; Mao S; Wu Q; Zhu M; Cao X; Wei B; Tian JM; Bao X; Ye X; Chen J; Wang S; Yu Y; Zhang H; Sun X; Cui ZN; Li YS; Wang H
Eur J Med Chem; 2023 Sep; 257():115462. PubMed ID: 37229830
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and bioactivity evaluation of novel indole-selenide derivatives as P-glycoprotein inhibitors against multi-drug resistance in MCF-7/ADR cell.
Yang Z; Luo D; Shao C; Hu H; Yang X; Cai Y; Mou X; Wu Q; Xu H; Sun X; Wang H; Hou W
Eur J Med Chem; 2024 Mar; 268():116207. PubMed ID: 38364715
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and bioactivity study on 5-phenylfuran derivatives as potent reversal agents against P-glycoprotein-mediated multidrug resistance in MCF-7/ADR cell.
Li YS; Yang X; Zhao DS; Cai Y; Huang Z; Wu R; Wang SJ; Liu GJ; Wang J; Bao XZ; Ye XY; Wei B; Cui ZN; Wang H
Eur J Med Chem; 2021 Apr; 216():113336. PubMed ID: 33725657
[TBL] [Abstract][Full Text] [Related]
6. Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo.
Zhang Z; Ma C; Li P; Wu M; Ye S; Fu L; Xu J
Cell Commun Signal; 2019 Sep; 17(1):110. PubMed ID: 31472682
[TBL] [Abstract][Full Text] [Related]
7. Discovery of a novel highly potent and low-toxic jatrophane derivative enhancing the P-glycoprotein-mediated doxorubicin sensitivity of MCF-7/ADR cells.
Maimaitijiang A; Wang B; Yang H; Tang D; Liu Y; Aisa HA
Eur J Med Chem; 2022 Dec; 244():114822. PubMed ID: 36242992
[TBL] [Abstract][Full Text] [Related]
8. Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents.
Qian J; Xia M; Liu W; Li L; Yang J; Mei Y; Meng Q; Xie Y
Eur J Pharmacol; 2019 Jun; 852():231-243. PubMed ID: 30959046
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and bioactivity study on oxygen-heterocyclic-based pyran analogues as effective P-glycoprotein-mediated multidrug resistance in MCF-7/ADR cell.
Abd El-Wahab AHF; Borik RMA; Al-Dies AM; Fouda AM; Mohamed HM; El-Eisawy RA; Mora A; El-Nassag MAA; Abd Elhady AM; Elhenawy AA; El-Agrody AM
Sci Rep; 2024 Mar; 14(1):7589. PubMed ID: 38555345
[TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis, and Biological Evaluation of Marine Lissodendrins B Analogues as Modulators of ABCB1-Mediated Multidrug Resistance.
Wang C; Zhang J; Wei X; Yang M; Ma W; Yu R; Liu M; Jiang T
Mar Drugs; 2023 May; 21(5):. PubMed ID: 37233508
[TBL] [Abstract][Full Text] [Related]
11. A novel flavonoid from Fissistigma cupreonitens, 5‑hydroxy‑7,8‑dimethoxyflavanone, competitively inhibited the efflux function of human P-glycoprotein and reversed cancer multi-drug resistance.
Teng YN; Lin KI; Lin YC; Thang TD; Lan YH; Hung CC
Phytomedicine; 2021 May; 85():153528. PubMed ID: 33735724
[TBL] [Abstract][Full Text] [Related]
12. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
Gu J; Fang X; Hao J; Sha X
Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500
[TBL] [Abstract][Full Text] [Related]
13. Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway.
Chen T; Wang C; Liu Q; Meng Q; Sun H; Huo X; Sun P; Peng J; Liu Z; Yang X; Liu K
Cancer Biol Ther; 2015; 16(1):106-14. PubMed ID: 25482933
[TBL] [Abstract][Full Text] [Related]
14. Targeting P-Glycoprotein: Nelfinavir Reverses Adriamycin Resistance in K562/ADR Cells.
Liu W; Meng Q; Sun Y; Wang C; Huo X; Liu Z; Sun P; Sun H; Ma X; Liu K
Cell Physiol Biochem; 2018; 51(4):1616-1631. PubMed ID: 30497065
[TBL] [Abstract][Full Text] [Related]
15. Jatrophane diterpenoids as multidrug resistance modulators from Euphorbia sororia.
Yang H; Mamatjan A; Tang D; Aisa HA
Bioorg Chem; 2021 Jul; 112():104989. PubMed ID: 34022709
[TBL] [Abstract][Full Text] [Related]
16. Novel virosecurinine bivalent mimetics as potent reversal agents against P-glycoprotein-mediated multidrug resistance.
Hou W; Meng Y; Xu XF; Huang ZX; Liu J; Wang ZY; Lin J; Chen WM
Eur J Med Chem; 2019 Dec; 183():111726. PubMed ID: 31585275
[TBL] [Abstract][Full Text] [Related]
17. Reversal of drug resistance by JS-K and nitric oxide in ABCB1- and ABCG2-expressing multi-drug resistant human tumor cells.
Sinha BK; Perera L; Cannon RE
Biomed Pharmacother; 2019 Dec; 120():109468. PubMed ID: 31605952
[TBL] [Abstract][Full Text] [Related]
18. Caffeic Acid Attenuates Multi-Drug Resistance in Cancer Cells by Inhibiting Efflux Function of Human P-glycoprotein.
Teng YN; Wang CCN; Liao WC; Lan YH; Hung CC
Molecules; 2020 Jan; 25(2):. PubMed ID: 31936160
[No Abstract] [Full Text] [Related]
19. Discovery of (quinazolin-6-yl)benzamide derivatives containing a 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline moiety as potent reversal agents against P-glycoprotein-mediated multidrug resistance.
Xue WH; Liu KL; Zhang TJ; Dong G; Wang JH; Wang J; Guo S; Hu J; Zhang QY; Li XY; Meng FH
Eur J Med Chem; 2024 Jan; 264():116039. PubMed ID: 38103540
[TBL] [Abstract][Full Text] [Related]
20. Bipiperidinyl derivatives of 23-hydroxybetulinic acid reverse resistance of HepG2/ADM and MCF-7/ADR cells.
Zhang DM; Li YJ; Shu C; Ruan ZX; Chen WM; Yiu A; Peng YH; Wang J; Lan P; Yao Z; Fung KP; Fu LW; Chen ZS; Ye WC
Anticancer Drugs; 2013 Jun; 24(5):441-54. PubMed ID: 23466650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]